Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis
Preeti Pandey, Kartikay Prasad, Amresh Prakash, et al.
Journal of Molecular Medicine (2020) Vol. 98, Iss. 12, pp. 1659-1673
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Structural biology of SARS-CoV-2: open the door for novel therapies
Weizhu Yan, Yanhui Zheng, Xiao‐Tao Zeng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 249
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 224
Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach
Chandra Bhushan Mishra, Preeti Pandey, Ravi Datta Sharma, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 1346-1360
Open Access | Times Cited: 91
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao, Rui Wang, Jiahui Chen, et al.
Chemical Reviews (2022) Vol. 122, Iss. 13, pp. 11287-11368
Open Access | Times Cited: 59
SARS-CoV-2 nonstructural protein 6 triggers endoplasmic reticulum stress-induced autophagy to degrade STING1
Pengtao Jiao, Wenhui Fan, Xiaoya Ma, et al.
Autophagy (2023) Vol. 19, Iss. 12, pp. 3113-3131
Open Access | Times Cited: 30
SARS-CoV-2 Non-Structural Proteins and Their Roles in Host Immune Evasion
Zheng Yao Low, Nur Zawanah Zabidi, Ashley Jia Wen Yip, et al.
Viruses (2022) Vol. 14, Iss. 9, pp. 1991-1991
Open Access | Times Cited: 38
Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
Yash Gupta, Oleksandr V. Savytskyi, Matt Coban, et al.
Molecular Aspects of Medicine (2022) Vol. 91, pp. 101151-101151
Open Access | Times Cited: 30
SARS-CoV-2: From the pathogenesis to potential anti-viral treatments
Peyman Kheirandish Zarandi, Mohammad Reza Zinatizadeh, Maryam Zinatizadeh, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111352-111352
Open Access | Times Cited: 33
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy
James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, et al.
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 6, pp. 435-449
Open Access | Times Cited: 33
Tetrahydrobenzo[h]quinoline derivatives as a novel chemotype for dual antileishmanial-antimalarial activity graced with antitubercular activity: Design, synthesis and biological evaluation
Tamer M. Ibrahim, Ghada Abada, Marcel Dammann, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115534-115534
Closed Access | Times Cited: 13
Dexamethasone in COVID-19 treatment: Analyzing monotherapy and combination therapy approaches
Seyed Mohammadmahdi Meybodi, Venus Shahabi Rabori, Darya Salkhorde, et al.
Cytokine (2024) Vol. 184, pp. 156794-156794
Closed Access | Times Cited: 4
Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis
Giovanna Fico, Ulker Isayeva, Michele De Prisco, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 30-44
Open Access | Times Cited: 19
New pyrazolylpyrazoline derivatives as dual acting antimalarial-antileishamanial agents: synthesis, biological evaluation and molecular modelling simulations
Adnan A. Bekhit, Eskedar T. Lodebo, Ariaya Hymete, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2320-2333
Open Access | Times Cited: 18
Unraveling the impact of polar solvation on the molecular geometry, spectroscopy (FT-IR, UV, NMR), reactivity (ELF, NBO, HOMO-LUMO) and antiviral inhibitory potential of Cissampeline by molecular docking approach
Michael O. Odey, Ekpo E. Antai, Eze A. Adindu, et al.
Chemical Physics Impact (2023) Vol. 7, pp. 100346-100346
Open Access | Times Cited: 10
Insights into SARS-CoV-2 structure: Approaches and action of SARS-CoV-2 main protease inhibitor
Ilma Shakeel, Aaliya Taiyab, Aanchal Rathi, et al.
Elsevier eBooks (2025), pp. 89-117
Closed Access
Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperatures
Yuri Furusawa, Maki Kiso, Ryuta Uraki, et al.
Journal of Virology (2025)
Open Access
The NSP6-L260F substitution in SARS-CoV-2 BQ.1.1 and XBB.1.16 lineages compensates for the reduced viral polymerase activity caused by mutations in NSP13 and NSP14
Yuri Furusawa, Kiyoko Iwatsuki‐Horimoto, Seiya Yamayoshi, et al.
Journal of Virology (2025)
Open Access
Simultaneous Inhibition of SARS-CoV-2 Entry Pathways by Cyclosporine
Kartikay Prasad, Shahzaib Ahamad, Kanipakam Hema, et al.
ACS Chemical Neuroscience (2021) Vol. 12, Iss. 5, pp. 930-944
Closed Access | Times Cited: 22
Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets
Tao Yang, Si Chun Wang, Linyan Ye, et al.
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 3, pp. 247-268
Closed Access | Times Cited: 8
Homology Modeling, de Novo Design of Ligands, and Molecular Docking Identify Potential Inhibitors of Leishmania donovani 24-Sterol Methyltransferase
Patrick O. Sakyi, Emmanuel Broni, Richard K. Amewu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 11
Insilico drug repurposing using FDA approved drugs against Membrane protein of SARS-CoV-2
K. Abraham Peele, Vikas Kumar, Shraddha Parate, et al.
Journal of Pharmaceutical Sciences (2021) Vol. 110, Iss. 6, pp. 2346-2354
Open Access | Times Cited: 14
Targeting cathepsins: A potential link between COVID-19 and associated neurological manifestations
Kartikay Prasad, Shahzaib Ahamad, Dinesh Gupta, et al.
Heliyon (2021) Vol. 7, Iss. 10, pp. e08089-e08089
Open Access | Times Cited: 14
Computer-aided discovery, design, and investigation of COVID-19 therapeutics
Chun-Chun Chang, Hao‐Jen Hsu, Tien‐Yuan Wu, et al.
Tzu Chi Medical Journal (2022) Vol. 34, Iss. 3, pp. 276-286
Open Access | Times Cited: 10
In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing
Ahmed Abdelkader, Amal A. Elzemrany, Mennatullah El-Nadi, et al.
Virology (2022) Vol. 573, pp. 96-110
Open Access | Times Cited: 9
Mutational analysis of flavonol synthase ofM. pinnatatowards enhancement of binding affinity: a computational approach
Garima Kumari, Vinod Kumar Nigam, Dev Mani Pandey
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-14
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top